Multiple Endocrine Neoplasia Type 2 — Trials

Multiple Endocrine Neoplasia Type 2 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00390325	Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer	completed	Phase 2	21	National Cancer Institute (NCI)NIH	1	Feb 6, 2024	clinicaltrials
NCT00514046	Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer	completed	Phase 1 / Phase 2	17	National Cancer Institute (NCI)NIH	1	Dec 22, 2020	clinicaltrials
NCT01424878	Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients	completed	—	150	National Cancer Institute (NCI)NIH	1	Apr 5, 2018	clinicaltrials

Data updated 22 days agoSource updated Feb 6, 2024source: clinicaltrials